Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Wyeth World Health Organization |
---|---|
Information provided by: | Wyeth |
ClinicalTrials.gov Identifier: | NCT00790998 |
This is a Phase 3 study comparing the efficacy, safety and tolerability of moxidectin and ivermectin in subjects infected with Onchocerca volvulus, which is the parasite that causes river blindness. Subjects participating in the study will be randomly assigned (by a 2 to1 ratio) to receive one orally-administered dose of either moxidectin or ivermectin.
Condition | Intervention | Phase |
---|---|---|
Onchocerciasis |
Drug: Moxidectin Drug: Ivermectin |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Single-Dose, Ivermectin-Controlled, Double-Blind, Efficacy, Safety and Tolerability Study of Orally Administered Moxidectin in Subjects Infected With Onchocerca Volvulus |
Estimated Enrollment: | 1500 |
Study Start Date: | December 2008 |
Estimated Study Completion Date: | August 2010 |
Estimated Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Moxidectin 8mg
|
Drug: Moxidectin |
2: Active Comparator
Ivermectin 150 mcg/kg
|
Drug: Ivermectin |
Ages Eligible for Study: | 12 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
Male and female subjects with Onchocerca volvulus infection
Exclusion criteria:
Pregnant or breast feeding women; coincidental loiasis Other exclusion criteria apply
Contact: Trial Manager | clintrialparticipation@wyeth.com |
Study Director: | Medical Monitor | Wyeth |
Responsible Party: | Wyeth ( Wyeth (Registry Contact: Clinical Trial Registry Specialist) ) |
Study ID Numbers: | 3110A1-3000 |
Study First Received: | November 13, 2008 |
Last Updated: | November 13, 2008 |
ClinicalTrials.gov Identifier: | NCT00790998 |
Health Authority: | Ghana: Ministry of Health |
onchocerciasis; river blindness; onchocerca volvulus moxidectin; ivermectin |
Pathological Conditions, Anatomical Skin Diseases Milbemycin Gastrointestinal Diseases Onchocerciasis Intestinal Volvulus Filariasis Nematode Infections Blindness |
Intestinal Diseases Intestinal Obstruction Skin Diseases, Infectious Digestive System Diseases Ivermectin Parasitic Diseases Congenital Abnormalities Helminthiasis |
Anti-Infective Agents Torsion Abnormality Spirurida Infections Antiparasitic Agents Skin Diseases, Parasitic |
Therapeutic Uses Anthelmintics Pharmacologic Actions Antinematodal Agents Secernentea Infections |